Literature DB >> 10933974

Gene therapy for ocular disease.

J Bennett1, A M Maguire.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10933974     DOI： 10.1006/mthe.2000.0080

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  12 in total

1.  Novel AAV serotypes for improved ocular gene transfer.

Authors:  Corinna Lebherz; Albert Maguire; Waixing Tang; Jean Bennett; James M Wilson
Journal:  J Gene Med       Date:  2008-04       Impact factor: 4.565

2.  TGF-β2-mediated ocular hypertension is attenuated in SPARC-null mice.

Authors:  Swarup S Swaminathan; Dong-Jin Oh; Min Hyung Kang; Allan R Shepard; Iok-Hou Pang; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-06-06       Impact factor: 4.799

3.  A comprehensive mutation analysis of RP2 and RPGR in a North American cohort of families with X-linked retinitis pigmentosa.

Authors:  Debra K Breuer; Beverly M Yashar; Elena Filippova; Suja Hiriyanna; Robert H Lyons; Alan J Mears; Bersabell Asaye; Ceren Acar; Raf Vervoort; Alan F Wright; Maria A Musarella; Patricia Wheeler; Ian MacDonald; Alessandro Iannaccone; David Birch; Dennis R Hoffman; Gerald A Fishman; John R Heckenlively; Samuel G Jacobson; Paul A Sieving; Anand Swaroop
Journal:  Am J Hum Genet       Date:  2002-04-30       Impact factor: 11.025

4.  Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice.

Authors:  Mariacarmela Allocca; Monica Doria; Marco Petrillo; Pasqualina Colella; Maria Garcia-Hoyos; Daniel Gibbs; So Ra Kim; Albert Maguire; Tonia S Rex; Umberto Di Vicino; Luisa Cutillo; Janet R Sparrow; David S Williams; Jean Bennett; Alberto Auricchio
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

Review 5.  Gene Therapy in the Anterior Eye Segment.

Authors:  Cynthia Amador; Ruchi Shah; Sean Ghiam; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Curr Gene Ther       Date:  2022       Impact factor: 4.391

6.  Gene therapy in glaucoma-3: Therapeutic approaches.

Authors:  Mohamed Abdel-Monem Soliman Mahdy
Journal:  Oman J Ophthalmol       Date:  2010-09

7.  Ocular localization and transduction by adenoviral vectors are serotype-dependent and can be modified by inclusion of RGD fiber modifications.

Authors:  Kazuhiro Ueyama; Keisuke Mori; Takuhei Shoji; Hidekazu Omata; Peter L Gehlbach; Douglas E Brough; Lisa L Wei; Shin Yoneya
Journal:  PLoS One       Date:  2014-09-18       Impact factor: 3.240

8.  An empty E1, E3, E4 adenovirus vector protects photoreceptors from light-induced degeneration.

Authors:  Hiroyasu Takita; Shin Yoneya; Peter L Gehlbach; Lisa L Wei; Keisuke Mori
Journal:  J Ocul Biol Dis Infor       Date:  2008-05-22

9.  Delivery of adeno-associated virus vectors to the fetal retina: impact of viral capsid proteins on retinal neuronal progenitor transduction.

Authors:  Enrico M Surace; Alberto Auricchio; Samuel J Reich; Tonia Rex; Ernest Glover; Stacey Pineles; Waixing Tang; Erin O'Connor; Arkady Lyubarsky; Andrey Savchenko; Edward N Pugh; Albert M Maguire; James M Wilson; Jean Bennett
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 10.  Pluripotent Stem Cell-Based Organoid Technologies for Developing Next-Generation Vision Restoration Therapies of Blindness.

Authors:  Ratnesh K Singh; Francois Binette; Magdalene Seiler; Simon M Petersen-Jones; Igor O Nasonkin
Journal:  J Ocul Pharmacol Ther       Date:  2020-10-14       Impact factor: 2.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.